ANGO - AngioDynamics beats top-line and bottom-line estimates; updates FY25 outlook
2025-04-02 06:34:51 ET
More on AngioDynamics
- AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares
- AngioDynamics: A Surgical Approach To Market Growth
- AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript
- AngioDynamics Non-GAAP EPS of -$0.04 beats by $0.07, revenue of $73.02M beats by $2.09M
- Seeking Alpha’s Quant Rating on AngioDynamics